Mental Health Agency Holds Mystery Meeting, Won't Say Why
Published Date: 1/17/2025
Notice
Summary
The National Institute of Mental Health is holding a private virtual meeting on February 6, 2025, to review contract proposals related to mental health research. This meeting affects researchers and companies submitting proposals, ensuring sensitive information stays confidential. No public attendance is allowed, and the decisions could impact future funding and projects.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed review may change funding outcomes
If you are a researcher or company submitting a contract proposal to the National Institute of Mental Health, a Special Emphasis Panel will review and evaluate proposals in a closed virtual meeting on February 6, 2025, from 11:00 a.m. to 3:00 p.m. The panel's decisions could affect future funding and projects for those proposers.
Meeting closed to protect confidential proposal details
The meeting on February 6, 2025 (11:00 a.m. to 3:00 p.m.) is closed to the public to prevent disclosure of confidential trade secrets, patentable material, and personal information tied to the contract proposals. This keeps sensitive proposal and personnel information from being publicly released.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-20710, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Modify the Required Criteria To Qualify for the Reduced Incremental Fee
Investors Exchange (IEX) is changing the rules for who can get a discount on certain trading fees. Starting November 1, 2026, members will need to meet new criteria to qualify for the reduced incremental fee, which could save or cost them money depending on their trading activity. This change affects all IEX members and kicks in right away to keep things fair and clear.
2026-20729, Proposed Agency Information Collection Activities; Comment Request
The National Credit Union Administration (NCUA) wants to update its Call Report form to include questions about credit unions’ activities with payment stablecoins. This change affects all credit unions and will start with reports due March 31, 2027. The NCUA is asking for public comments by December 8, 2026, to make sure the new form works well without causing extra costs or hassle.
2026-20702, Notice of Public Meetings of the Virginia Advisory Committee to the U.S. Commission on Civil Rights
The Virginia Advisory Committee to the U.S. Commission on Civil Rights is holding virtual public meetings to discuss how Virginia public universities are following rules about fair student admissions. Anyone interested can join these Zoom meetings on October 27, November 10, and December 15, 2026, to listen and share their thoughts. These meetings don’t cost money to attend, but phone users might pay regular call fees.
2026-20708, Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX Rule 15.110(a) and (c) To Amend the IEX Equities Fee Schedule
IEX is shaking up its fee schedule starting November 1, 2026, by tweaking who gets rebates for adding displayed liquidity and changing rebate amounts. This affects IEX members who trade stocks, giving them new ways to save or earn more on fees. The changes kick in right away after filing, so traders should get ready to adjust their strategies and cash flow.
2026-20730, Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications; Correction
The FDA fixed a previous announcement about pulling approval for 16 generic drug applications. Three drugs from Navinta LLC—ribavirin solution, fosaprepitant powder, and nicardipine capsules—won't lose approval because Navinta asked to keep them active. This means those three drugs stay on the market, while the other 13 still had their approvals withdrawn as planned back in July 2026.
2026-20779, Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Review; 2024-2025
The U.S. Department of Commerce found that tires from Thailand were sold in the U.S. for less than their normal price between July 2024 and June 2025. This means some importers might have to pay extra duties to keep things fair. The review process had some delays due to government shutdowns, but now the preliminary results are out and open for comments.
Previous / Next Documents
Previous: 2025-01072, Revised Designation Decision and Record of Decision in Response to a Petition by Amigos Bravos for a Determination That Stormwater Discharges in Los Alamos County Contribute to Water Quality Standards Violations and Require Clean Water Act Permit Coverage
The EPA has decided that stormwater runoff from Los Alamos County, including the Los Alamos National Laboratory, is polluting local waters and must now follow Clean Water Act permit rules. This means local government and lab operators will need to manage their stormwater better to protect water quality. The new rules were finalized in December 2024 and could mean some new costs and efforts to keep water clean.
Next: 2025-01076, National Heart, Lung, and Blood Institute; Notice of Closed Meetings
The National Heart, Lung, and Blood Institute is holding three closed virtual meetings in February 2025 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding to support important health research. If you’re applying for grants or contracts, these dates are key for your funding chances!